Saturated fatty acid (SFA)

Saturated fatty acids (SFAs) are a class of organic molecules characterized by a hydrocarbon chain containing only single bonds, rendering them typically solid at room temperature. They are essential for various biological processes, serving as a high-density energy source and as fundamental structural components of the phospholipid bilayer in cell membranes [7, 14]. SFAs also play critical roles in cellular signaling, such as through the process of palmitoylation, which stabilizes membrane proteins, and as precursors for the synthesis of vital hormones [11]. While they occur naturally in many foods, they are not specific therapeutic targets in the conventional sense of druggable proteins, but rather metabolic ligands whose excessive presence drives pathological states [1, 3]. Clinically, SFAs are significant due to their role in promoting chronic inflammation and cardiovascular disease. High concentrations of long-chain SFAs, like palmitic acid, trigger the CD14-TLR4-MD2 receptor complex, initiating pro-inflammatory cytokine production via the NF-κB pathway [4, 5]. This immune activation, combined with the induction of ER stress and elevated LDL cholesterol levels, contributes to the progression of atherosclerosis, insulin resistance, and type 2 diabetes [12, 18, 21]. Therapeutic strategies aimed at modulating the effects of saturated fats focus on inhibiting their absorption through drugs like Orlistat or managing the resulting hyperlipidemia with agents like Statins [10, 25].

Other names

Saturated fatSaturated fatty acidsSolid fatPalmitic acidStearic acid

Saturated fatty acids (SFAs) act as non-microbial agonists for the Toll-like receptor 4 (TLR4) complex, particularly via CD14 and MD2, triggering pro-inflammatory NF-κB signaling [4, 5]. They also induce endoplasmic reticulum (ER) stress by activating the IRE1α pathway in macrophages [8] and serve as substrates for hepatic triglyceride synthesis, leading to increased low-density lipoprotein (LDL) cholesterol levels [17, 21].